Consequences of Infective Endocarditis, And the Effective of Antibiotics Treatments: Review
|
|
- Prosper Armstrong
- 5 years ago
- Views:
Transcription
1 Consequences of Infective Endocarditis, And the Effective of Antibiotics Treatments: Review 1 Nasser Mohammed Abdullah Alshahrani, 2 Abdullah Saad Judaya Alshahrani, 3 Fayez abdulrahman fayez alshahrani, 4 Saeed Faleh Saeed Al Shahrani, 5 Abdullah saad amer alshahrani, 6 Abdulrahman Mubarak Abdulrahman Albishi, 7 Abdualla Mohammed A Alshahrani, 8 Abdulraheem Ali Alzahrani Abstract: Staphylococcus aureus is the most common organism. Approximately 30% of those having bacteremia with staphylococcus will develop endocarditis. This review was aimed to discuss the complications following infective endocarditis, and also overview the proper antibiotics treatment, and how effective could be this option of treatment over other options, we also indented to overview the risk factors and epidemiology of infective endocarditis in most evidence based review. We searched, with English language restrictions, and only human subject articles following electronic databases; PubMed, MEDLINE and EMBASE for any relevant article, whether was it reviews or randomized controlled studies or systematic reviews discussing infective endocarditis from the time of databases inception to December We used the term infective endocarditis for the Mesh keyword. Date last search performed was December, Optimal antibiotic recommending for enterococcal IE requires that MICs of penicillin, amoxicillin, aminoglycosides, and glycopeptides be determined. When the strain shows only low level resistance to aminoglycoside, advised therapy is a combination of high dose β lactam ( million units/day penicillin or 200 mg/kg/day amoxicillin) plus gentamicin for 4-6 weeks. The aminoglycoside element ought to be administered in two or three equally divided doses; this suggestion is based on outcomes of speculative studies. When it comes to high level resistance to gentamicin, cross resistance may be expected with all other aminoglycosides, other than often streptomycin Keywords: Staphylococcus aureus, infective endocarditis, MICs of penicillin, amoxicillin, aminoglycosides. 1. INTRODUCTION In developed countries, the occurrence of infective endocarditis (IE) varies from 3 to 9 cases per annually, and it is twice as common in males (1,2,3). Staphylococcus aureus is the most common organism. Approximately 30% of those having bacteremia with staphylococcus will develop endocarditis (4). Patients with valvular abnormalities, such as prostheses, mitral regurgitation (MR), or aortic stenosis or with endocardial damage from distributing particulate matter as from intravenous (IV) drug use, are at the greatest risk of contracting endocarditis. Indeed, some 75% of patients with IE have structurally abnormal hearts (4). In addition to host factors, IE advancement likewise overwhelmingly includes microorganisms that have certain attributes, such as platelet aggregating abilities. Staphylococcus and Streptococcus species are the most typical etiologic agents of IE, owing in part to this capacity (4). Capability of the microbe to activate platelets creates an environment conducive to vegetation formation and in theory supports the use of antiplatelet agents in the management of disease. However, studies of antiplatelet usage in neurological complications of endocarditis have had negative or neutral results (5,6). IE is more common in guys than ladies (7), and is more typical with increasing age (8). The mean age of IE patients has increased over time, from under 30 years in the pre-antibiotic age (9) to nearly 60 years in 1990s (10). In the elderly, IE is more often related to intracardiac prosthetic devices and bacteria from the gastrointestinal system (11). In a big observational accomplice study, IE most commonly included the mitral valve just (approximately 40% of patients), Page 861
2 followed by the aortic valve only (36% of patients), followed by multivalvular disease (10,12). Right-sided valves are rarely affected except among injection drug users. The pulmonic valve is least most likely to be associated with IE. Structural heart problem is a risk factor for IE because it leads to turbulent blood circulation. About 75% of patients who establish IE have underlying structural heart problem (13). In the past, rheumatic heart disease with mitral stenosis was the most typical valvular problem in patients with IE. Recently, the most typical predisposing lesions are mitral regurgitation, aortic valve disease (stenosis and regurgitation), and congenital heart disease (14,15). Mitral valve prolapse is a risk factor for IE, primarily when regurgitation is present (16). OBJECTIVE: This review was aimed to discuss the complications following infective endocarditis, and also overview the proper antibiotics treatment, and how effective could be this option of treatment over other options, we also indented to overview the risk factors and epidemiology of infective endocarditis in most evidence based review. 2. METHODOLOGY We searched, with English language restrictions, and only human subject articles following electronic databases; PubMed, MEDLINE and EMBASE for any relevant article, whether was it reviews or randomized controlled studies or systematic reviews discussing infective endocarditis from the time of databases inception to December We used the term infective endocarditis for the Mesh keyword. Date last search performed was December, We supplemented the search with references from articles reviewed and correspondence with other researchers, including experts in the field. When a reference was deemed potentially suitable for inclusion, a full-text copy was obtained and reviewed according to our study criteria which are obvious in the objective of this study. Epidemiological overview: 3. RESULTS & DISCUSSION The epidemiological profile of infective endocarditis (IE) has altered dramatically over the last few years (17). When a disease impacting young people with previously well identified valve disease mostly rheumatic disease IE is now impacting older patients, a significant percentage of whom has no previously known valve disease and develop IE as the result of health care associated treatments (18). The occurrence of IE differs from nation to country, which may show more methodological differences in surveys than true occurrence variations. In an epidemiologic study performed in Sweden from 1984 to 1988 the incidence of IE was 5.9 episodes/ person years after adjusting for both age and sex (19). Throughout a comparable period, the overall occurrence of IE was 9.29 episodes/ person years in the Philadelphia city, which was up to 5.02 episodes/ person years when cases involving intravenous drug users were excluded (20). In the 1990s, French private investigators carried out two epidemiologic surveys in three areas of France that represented about 25% of the entire French population. In 1991 their survey discovered the unrefined occurrence to be 2.24 episodes/ person years, which increased to 2.43 episodes/ person years after change for age and sex (21). Complications of Infective endocarditis and their management: Encephalopathy: Encephalopathy is a typical issue of IE that need to trigger more workup. Encephalopathy might be secondary to systemic insults such as fever, azotemia, electrolyte disturbances, or hypercarbia or point to underlying main nerve system participation through ischemic stroke, hemorrhage, cerebral abscess, or meningitis as gone over subsequently (22). Severe ischemic stroke is the most typical neurological issue of IE, manifesting scientifically in 20% to 40% of patients with IE (23,24,25). Asymptomatic ischemia acknowledged by neuroimaging studies occurs in another 30% to 40% of patients (23,26). Thus, ischemic stroke may be most likely than not in patients with IE. There are some scenarios where the risk of cerebral ischemia is more likely. Anterior mitral valve leaflet endocarditis provides the greatest risk (27). Second, left-sided endocarditis is connected with a much higher risk of stroke than right-sided IE. Third, S aureus infection, before or less than 1 week after initiation of antibiotics, increases the likelihood of stroke. The system of acute cerebral ischemia in IE is likely embolic. Ischemic strokes in IE most frequently occur in the middle cerebral artery territory (Figure 1) (27). Page 862
3 Figure 1: Stroke complicating endocarditis. Axial diffusion-weighted imaging (left) and T2 fluid-attenuated inversion recovery (FLAIR) imaging (right) of a 64-year-old female with a history of severe mitral regurgitation who presented with confusion 2 weeks after a dental procedure. Imaging shows a large right middle cerebral artery territory embolic infarct. The patient was found to have Streptococcus mitis bacteremia and mitral valve endocarditis. Vessel imaging was patent, and she underwent successful valve repair 2 weeks after antibiotics were started. (27) Management of stroke in the setting of IE varies from that of stroke due to noninfective mechanisms insofar as anticoagulation and antiplatelet agents are contraindicated, a minimum of acutely (27). Assessment of cardiac function may reveal a sign for valvular surgical intervention, and stroke complicating IE can affect the timing of this, as talked about further on. Thrombolytic therapy with recombinant tissue plasminogen activator (r-tpa) or related agents has not been well studied in IE-related stroke. In the biggest case series (28), 4 patients having IE presented with ischemic stroke and were treated with thrombolysis. All 4 established hemorrhage after IV r-tpa, 3 of whom passed away. For this reason and due to bad results with intense anticoagulation, r-tpa might increase the risk of bleeding in these patients. The management distinctions to other kinds of ischemic stroke posture a prospective medical problem in the circumstance where stroke is the presenting sign of IE. If a patient appears with a stroke that is amenable to thrombolytic treatment, antiplatelet representatives, or anticoagulation, one might unintentionally use a thrombolytic drug in a patient with occult endocarditis, therefore precipitating disastrous results (28). Cerebral microhemorrhage is significantly acknowledged as a silent issue of endocarditis (26,29) and recently has been implicated in anticipating obvious hemorrhage (30). Cerebral microhemorrhage has actually been detected in 57% of cases with IE, typically situated cortically and with approximately about 8 microbleeds per patient (26). The proposed system is that of infective vasculitis (31) although this is speculative. Furthermore, although there is no information linking the existence of microhemorrhage to later on overt hemorrhage when antiplatelet agents or anticoagulants are used, there could be an increased risk in this setting. Antibiotic prophylaxis to prevent infective endocarditis: Infective endocarditis is a unusual however serious and typically life threatening condition. The pathogenesis of infective endocarditis comprises of an intricate series of events (32). Anatomic localization of infection is identified by the adherence of microorganisms to various sites (33). The coincidence in between bacterial infection and endocarditis was described prior to the turn of 20th century (34). Studies have shown that oral procedures are trigger factors for few cases of endocarditis (35,36). A poor condition of the gum health is a considerable risk factor (37). Lockhart reported more incidence of infective endocarditis following dental extraction and periodontal surgical treatment (38). Ottent et al reported that bacteremia was associated with 74% of patients following tooth extraction (39). Antibiotic prophylaxis not just acts by destroying bacteria, however also by preventing bacterial adherence (40). It is shown in high risk oral procedures in patients with pre-existing high rate cardiac disorders (42). The basic program includes high dosages of amoxicillin in adults and children, one hour prior to the oral treatment. 2 g of oral amoxicillin must be given to grownups prior to the oral procedure beginning (43). Dajani et al have reported that 2g of amoxicillin offers a number of hours of antibiotic coverage (44). Clindamycin is recommended in patients adverse beta- lactamics (45). Furthermore, finest results have actually been attained by use of clindamycin in treating odontogenic infections (46). Vancomycin and streptomycin are used prophylactically for prevention of infective endocarditis in patients with prosthetic heart valves. If the proper antibiotic is Page 863
4 not chosen (47), prophylactic failure is possible to occur in patients with congenital heart disease. The neglect to administer antibiotic prophylaxis for dental treatments may lead to SBE and will result in worst consequences for the patient. Cunha et al documented a comparable case which, resulted in a cerebral vascular accident, embolic occlusion of the leg, and mitral valve replacement (48). On the other hand, a decrease of 78.6% in prescribing antibiotics was seen after the unveiling of NICE guideline (49). The French agency for Health Product Health Safety advices against or contraindicates oral facial surgery, bone surgery, periodontal surgery, root canal treatment in these patients except under emergency situation situations, as these patients are prone to high risk of infection (50). Clinical effectiveness of antibiotic treatment of IE: The intravenous route for antibiotic administration is the very best because it provides optimum bioavailability. A lot of antibiotics are administered as brief infusions (30 minutes). There are some exceptions, nevertheless. Since of the risk of seizures secondary to the high serum concentrations achieved with periodic infusion, penicillin G is normally administered continually. One to two hour infusions of vancomycin enhance the tolerability of the drug. For prescription antibiotics with time dependent impacts (β lactams), the period between infusions should be adjusted to take the elimination half life into account. For prescription antibiotics with concentration dependent impacts (aminoglycosides), two times or thrice daily administration is recommended. There are scientific and experimental data in favour of oncedaily administration of gentamicin or netilmicin in IE caused by penicillin sensitive streptococci (50,51,52). Both the efficacy and the tolerance of the treatment need to be carefully kept an eye on. In terms of effectiveness, apart from the lack of relapse at the end of the treatment, there is no completely trustworthy scientific or biological criterion. This emphasises the significance of biological and scientific security (disappearance of fever, sterilisation of blood cultures, and normalisation of inflammation markers) throughout treatment and in the subsequent four weeks (duration of optimum risk of regression of IE). The decision of blood concentrations of prescription antibiotics, particularly aminoglycosides, is useful to confirm both that the peak concentrations are high enough (effectiveness objective) and that the trough concentrations are not exceedingly high (tolerance goal). The most current recommendations for the antibiotic treatment of IE were provided by the European Society of Cardiology (53) and the American Heart Association (54). are summed up in (Table 1 and 2). Table 1: Antibiotic treatment for infective endocarditis caused by penicillin susceptible (MIC <0.1 mg/l) or penicillin relatively resistant (0.1< MIC 0.5 mg/l) streptococcal endocarditis (53,54) No allergy to penicillin Allergy to penicillin Drug Dosage Drug Dosage Penicillin susceptible streptococci (MIC <0.1 mg/l) Non complicated native valve IE Complicated and/or prosthetic valve IE *Other choice: netilmicin (5 6 mg/kg/d); for both drugs, once daily administration. Including tolerant streptococci (MBC/MIC >32) for which amoxicillin is to be preferred to penicillin. IE, infective endocarditis; MBC, minimal bactericidal concentration; MIC, minimal inhibitory concentration. Duration Penicillin G U/kg/d Vancomycin 30 mg/kg/d 2 weeks or amoxicillin 100 mg/kg/d or teicoplanin 6 10 mg/kg/d combination or ceftriaxone 2 g/d ± gentamicin* 3 mg/kg/d or 4 weeks β lactam ± gentamicin* 3 mg/kg/d Penicillin G U/kg/d Vancomycin 30 mg/kg/d 2 weeks combination or amoxicillin 100 mg/kg/d or teicoplanin 6 10 mg/kg/d weeks β lactam + gentamicin* 3 mg/kg/d ± gentamicin* 3 mg/kg/d Penicillin relatively resistant streptococci G (0.1< MIC 0.5 mg/l) Non complicated native valve IE Complicated and/or prosthetic valve IE Penicillin G U/kg/d Vancomycin 30 mg/kg/d 2 weeks combination or amoxicillin 200 mg/kg/d or teicoplanin 6 10 mg/kg/d + 2 weeks β lactam + gentamicin* 3 mg/kg/d + gentamicin* 3 mg/kg/d Penicillin G U/kg/d Vancomycin 30 mg/kg/d 2 weeks combination or amoxicillin 200 mg/kg/d or teicoplanin 6 10 mg/kg/d weeks β lactam + gentamicin* 3 mg/kg/d + gentamicin* 3 mg/kg/d Page 864
5 Table 2: Antibiotic treatment for enterococcal, nutritionally variant and penicillin resistant (MIC >0.5 mg/l) streptococcal endocarditis (54,55) No allergy to penicillin Allergy to penicillin Condition Enterococcal strain susceptible to penicillin, aminoglycosides, and vancomycin Enterococcal strain susceptible to penicillin, streptomycin, vancomycin, and resistant to gentamicin Enterococcal strain resistant to penicillin (intrinsic resistance), susceptible to gentamicin and vancomycin Enterococcal strain resistant to penicillin (β lactam producing), susceptible to gentamicin and vancomycin Streptococcal and enterococcal strains with high level resistance to all aminoglycosides E faecalis resistant to penicillin, aminoglycosides and vancomycin E faecium resistant to penicillin, aminoglycosides and vancomycin Drug Dosage Drug Dosage Duration Amoxicillin or 200 mg/kg/d Vancomycin 30 mg/kg/d 4 6 penicillin G U/kg/d or teicoplanin 6 10 mg/kg/d weeks + gentamicin* 3 mg/kg/d + gentamicin* 3 mg/kg/d Amoxicillin or 200 mg/kg/d Vancomycin 30 mg/kg/d 4 6 penicillin G U/kg/d or teicoplanin 6 10 mg/kg/d weeks + streptomycin 15 mg/kg/d + streptomycin 15 mg/kg/d Vancomycin 30 mg/kg/d Vancomycin 30 mg/kg/d 6 weeks or teicoplanin 6 10 mg/kg/d or teicoplanin 6 10 mg/kg/d + gentamicin* 3 mg/kg/d + gentamicin* 3 mg/kg/d Co amoxyclav 175 mg/kg/d amoxicillin Vancomycin 30 mg/kg/d 6 weeks + gentamicin* 3 mg/kg/d or teicoplanin 6 10 mg/kg/d + gentamicin* 3 mg/kg/d Amoxicillin >200 mg/kg/d Vancomycin 30 mg/kg/d 8 weeks Amoxicillin 200 mg/kg/d 8 + ceftriaxone or 2 g/d weeks imipenem 2 g/d Linezolid, or 1200 mg/d Linezolid, or 1200 mg/d 8 quinupristindalfopristin 22.5 mg/kg/d quinupristindalfopristin 22.5 mg/kg/d weeks *Two or three daily doses. Duration of aminoglycoside administration could be shortened to 2 3 weeks; the total duration of treatment should be 6 weeks when vancomycin or teicoplanin are used. Two daily doses. 4. CONCLUSION Optimal antibiotic recommending for enterococcal IE requires that MICs of penicillin, amoxicillin, aminoglycosides, and glycopeptides be determined. When the strain shows only low level resistance to aminoglycoside, advised therapy is a combination of high dose β lactam ( million units/day penicillin or 200 mg/kg/day amoxicillin) plus gentamicin for 4-6 weeks. The aminoglycoside element ought to be administered in two or three equally divided doses; this suggestion is based on outcomes of speculative studies. When it comes to high level resistance to gentamicin, crossresistance may be expected with all other aminoglycosides, other than often streptomycin. If the stress reveals low level resistance to streptomycin, the latter can be utilized in mix with high doses of a cell wall active representative, either a glycopeptide or a β lactam. The best treatment choice is monotherapy with amoxicillin or a glycopeptide provided at high Page 865
6 dosage for at least 8 weeks if the pressure shows high level resistance to streptomycin as well. Even with such extended treatment, antibiotic therapy often stops working, and surgical treatment is most likely to be needed. REFERENCES [1] Hoen B, Duval X.. Infective endocarditis. N Engl J Med. 2013;369 (8):785. [2] Hoen B, Duval X.. Clinical practice. Infective endocarditis. N Engl J Med. 2013;368 (15): [3] Sy RW, Kritharides L.. Health care exposure and age in infective endocarditis: results of a contemporary populationbased profile of 1536 patients in Australia. Eur Heart J. 2010;31 (15): [4] Keynan Y, Rubinstein E.. Pathophysiology of infective endocarditis. Curr Infect Dis Rep. 2013;15 (4): [5] Chan KL, Dumesnil JG, Cujec B, et al.. A randomized trial of aspirin on the risk of embolic events in patients with infective endocarditis. J Am Coll Cardiol. 2003;42 (5): [6] Chan KL, Tam J, Dumesnil JG, et al.. Effect of long-term aspirin use on embolic events in infective endocarditis. Clin Infect Dis. 2008;46 (1):37 4. [7] Fowler VG, Scheld WM, Bayer AS. Endocarditis and intravascular infections. In: Mandell GL, Bennett JE, Dolin R, editors. Mandell, Douglas and Bennett s Principles and Practice of Infectious Diseases. 6. Philadelphia: Churchill Livingstone; pp [8] Cabell CH, Fowler VG, Jr, Engemann JJ, et al. Endocarditis in the elderly: Incidence, surgery, and survival in 16,921 patients over 12 years. Circulation. 2002;106(19):547. [9] Thayer WS. Studies on bacterial (infective) endocarditis. Johns Hopkins Hosp Rep. 1926;22:1 8. [10] Miro JM, Anguera I, Cabell CH, et al. Staphylococcus aureus native valve infective endocarditis: Report of 566 episodes from the International Collaboration on Endocarditis Merged Database. Clin Infect Dis. 2005;41: [11] Selton-Suty C, Hoen B, Grentzinger A, et al. Clinical and bacteriological characteristics of infective endocarditis in the elderly. Heart. 1997;77(3): [12] McDonald JR, Olaison L, Anderson DJ, et al. Enterococcal native valve endocarditis: Report of 107 episodes from the International Collaboration on Endocarditis Merged Database. Am J Med. 2005;11: [13] Griffin MR, Wilson WR, Edwards WD, et al. Infective endocarditis. Olmsted County, Minnesota, 1950 through JAMA. 1985;254: [14] Michel PL, Acar J. Native cardiac disease predisposing to infective endocarditis. Eur Heart J. 1995;16(SupplB):2 9. [15] Weinberger I, Rotenberg Z, Zacharovitch D, et al. Native valve infective endocarditis in the 1970s versus 1980s: underlying cardiac lesions and infecting organisms. Clin Cardiol. 1990;13:94 8. [16] Clemens JD, Horwitz RI, Jaffe CC, et al. A controlled evaluation of the risk of bacterial endocarditis in persons with mitral-valve prolapse. N Engl J Med. 1982;307: [17] Moreillon P, Que Y A. Infective endocarditis. Lancet [18] Hoen B, Alla F, Béguinot I. et al Changing profile of infective endocarditis results of a one year survey in France in JAMA [19] Hogevik H, Olaison L, Andersson R. et al Epidemiologic aspects of infective endocarditis in an urban population. A 5 year prospective study. Medicine (Baltimore) [20] Berlin J A, Abrutyn E, Strom B L. et al Incidence of infective endocarditis in the Delaware Valley, Am J Cardiol [21] Delahaye F, Goulet V, Lacassin F. et al Characteristics of infective endocarditis in France in A 1 year survey. Eur Heart J Page 866
7 [22] Morris NA, Matiello M, Lyons JL, Samuels MA. Neurologic Complications in Infective Endocarditis: Identification, Management, and Impact on Cardiac Surgery. Lyons J, ed. The Neurohospitalist. 2014;4(4): doi: / [23] Snygg-Martin U, Gustafsson L, Rosengren L, et al.. Cerebrovascular complications in patients with left-sided infective endocarditis are common: a prospective study using magnetic resonance imaging and neurochemical brain damage markers. Clin Infect Dis. 2008;47 (1):23 30 [24] Sonneville R, Mirabel M, Hajage D, et al.. Neurologic complications and outcomes of infective endocarditis in critically ill patients: the ENDOcardite en REAnimation prospective multicenter study. Crit Care Med. 2011;39 (6): [25] Novy E, Sonneville R, Mazighi M, et al.. Neurological complications of infective endocarditis: New breakthroughs in diagnosis and management. Med Mal Infect. 2013;43 (11-12): [26] Hess A, Klein I, Iung B, et al.. Brain MRI findings in neurologically asymptomatic patients with infective endocarditis. AJNR Am J Neuroradiol. 2013;34 (8): [27] Derex L, Bonnefoy E, Delahaye F.. Impact of stroke on therapeutic decision making in infective endocarditis. J Neurol. 2010;257 (3): [28] Walker KA, Sampson JB, Skalabrin EJ, Majersik JJ.. Clinical characteristics and thrombolytic outcomes of infective endocarditis-associated stroke. Neurohospitalist. 2012;2 (3):87 91 [29] Klein I, Iung B, Labreuche J, et al.. Cerebral microbleeds are frequent in infective endocarditis: a case-control study. Stroke. 2009;40 (11): [30] Okazaki S, Sakaguchi M, Hyun B, et al.. Cerebral microbleeds predict impending intracranial hemorrhage in infective endocarditis. Cerebrovasc Dis. 2011;32 (5): [31] Klein I, Iung B, Wolff M, et al.. Silent T2* cerebral microbleeds: a potential new imaging clue in infective endocarditis. Neurology. 2007;68 (23):2043. [32] Gopalakrishnan PP, Shukla SK, Tak T. Infective Endocarditis: Rationale for revised guidelines for antibiotic prophylaxsis. Clin Med Res. 2009;7(3): [33] Wilson W, Taubert KA, Gewitz M, Lockhart PB, Baddour LM, Levison M, et al. Prevention of infective endocarditis. Guidelines from the American Heart Association Circulation Oct 9. Circulation. 2007: [34] Cowper T. Pharmacologic mamagement of the patient with disorders of the cardiovascular system: Infective endocarditis. Dent Clinic North Am. 1996;40: [35] Vander Meer JT, Thompson J, Valkenburg HA, Michael MF. Epidemology of bacterial endocarditis in the Netherlands II antecedent procedures and uses of prophylaxis. Arch Intern Med. 1992;152: [36] Storm BL, Abruptyn E, Berlin JA, Finman JL, Feldman RS, Stolley PD, et al. Dental and cardiac risk factors for infective endocarditis. A population based case-control study. Arch Intern Med. 1998;129: [37] Guntheroth WG. How important are dental procedures as a cause of infective endoarditis. Am J Cardiol. 1984;54: [38] Lockhart PB. An analysis of bacteremias during dental extraction. A double-blind placebo-controlled study of chlorhexidine. Arch Intern Med. 1996;156: [39] Otten JE, Pelz K, Christmann G. Anaerobic bacteremia following tooth extraction and removal of osteosynthesis plates. J Oral Maxillofac Surg. 1987;45: [40] Gauser MP, Bernard JP, Moreillon P, Francioli P. Succesful single dose amoxicillin prophylaxis against experimental streptococcal endocarditis: evidence for two mechanisms of protection. J Infect Dis. 1983;147: [41] Vera JRM, Gomez-Lus Centelles ML. Antimicrobial prophylaxis in oral surgery and dental procedures. Med Oral Patol Circ Buccal. 2007;12: Page 867
8 [42] Dajani AS, Taubert KA, Wilson W, Bolger AF, Bayer A, Ferrieri P, Gewitz MH, et al. Prevention of bacterial endocarditis: Recommendations by the American heart association. Clinic Infect Dis. 1979;25: [43] Dajani A, Bawden RE, Berry MC. Oral amoxicillin as a prophylaxis for endocarditis: What is the optimal dose. Clin Infect Dis. 1994;18: [44] Durack DT. Prophylaxis of infective endocarditis. In: Mandell GL, Bennett JE, Dolin R, editors. Mandell, Douglas and Bennett principles and practice of infectious diseases. 6th ed. Philadelphia: Elsevier Churchill Livingstone; pp [45] Gilmore WC, Jacobus NV, Gorbach SL, Doku HC. A prospective double-blind evaluation of penicillin versus clindamycin in the treatment of odontofenic infections. J Oral Maxillofac Surg. 1988;46: [46] Pogrel MA, Welsby PD. The dentist and prevention of infective endocardititis. Br Dent J. 1975;139: [47] Cunha BA, D'Ella AA, Pawar N, Scoch D. Viridans streptococcal (Streptococcus intermedius) mitral valve sub acute bacterial endocarditis( SBE) in a patient with mitral valve prolapsed after a dental procedure: the importance of antibiotic prophylaxis. Heart Lung. 2010;39(1): [48] Thornhill MH, Dayer MJ, Forde JM, Corey GR, Hock G, Chu VH, et al. Impact of the NICE guideline recommending cessation of antibiotic prophylaxis for prevention of infective endocarditis: before and after study. BMJ. 2011;342:d2392. [49] French Health Products Safety Agency Prescribing antibiotics in odontology and stomatology. Recommendations by the French Health Products Safety Agency. Fundament Clin Pharmacol. 2003;17: [50] Blatter M, Fluckiger U, Entenza J. et al Simulated human serum profiles of one daily dose of ceftriaxone plus netilmicin in treatment of experimental streptococcal endocarditis. Antimicrob Agents Chemother [51] Francioli P, Ruch W, Stamboulian D. Treatment of streptococcal endocarditis with a single daily dose of ceftriaxone and netilmicin for 14 days: a prospective multicenter study. Clin Infect Dis [52] Sexton D J, Tenenbaum M J, Wilson W R. et al Ceftriaxone once daily for four weeks compared with ceftriaxone plus gentamicin once daily for two weeks for treatment of endocarditis due to penicillin susceptible streptococci. Clin Infect Dis [53] Horstkotte D, Follath F, Gutschik E. et al Guidelines on prevention, diagnosis and treatment of infective endocarditis executive summary; the task force on infective endocarditis of the European Society of Cardiology. Eur Heart J [54] Baddour L M, Wilson W R, Bayer A S. et al Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America. Circulation e394 e434.e434o Page 868
Endocardite infectieuse
Endocardite infectieuse 1. Raccourcir le traitement: jusqu où? 2. Proposer un traitement ambulatoire: à partir de quand? Endocardite infectieuse A B 90 P = 0.014 20 P = 0.0005 % infective endocarditis
More informationThis is a repository copy of Antibiotic prophylaxis of endocarditis: a NICE mess.
This is a repository copy of Antibiotic prophylaxis of endocarditis: a NICE mess. White Rose Research Online URL for this paper: http://eprints.whiterose.ac.uk/96643/ Version: Accepted Version Article:
More informationAntibiotic treatment of streptococcal and enterococcal endocarditis: an overview
European Heart Journal (1995) 16 {Supplement B), 75-79 Antibiotic treatment of streptococcal and enterococcal endocarditis: an overview P. FRANCIOLI Division of Hospital Preventative Medicine and Department
More informationNew guidelines for the antibiotic treatment of streptococcal, enterococcal and staphylococcal endocarditis. D. C. Shanson
Journal of Antimicrobial Chemotherapy (1998) 42, 292 296 New guidelines for the antibiotic treatment of streptococcal, enterococcal and staphylococcal endocarditis JAC D. C. Shanson Microbiology Department,
More informationDaniel C. DeSimone, MD Assistant Professor of Medicine
Daniel C. DeSimone, MD Assistant Professor of Medicine Faculty photo will be placed here Desimone.Daniel@mayo.edu 2015 MFMER 3543652-1 Infective Endocarditis Mayo School of Continuous Professional Development
More informationOverview. Clinical Scenario. Endocarditis: Treatment & Prevention. Prophylaxis The Concept. Jeremy D. Young, MD, MPH. Division of Infectious Diseases
Endocarditis: Treatment & Prevention Jeremy D. Young, MD, MPH Division of Infectious Diseases Clinical Scenario Patient with MVP scheduled to have wisdom teeth extracted. Has systolic murmur with mid-systolic
More informationSupplementary appendix
Supplementary appendix This appendix formed part of the original submission and has been peer reviewed. We post it as supplied by the authors. Supplement to: Dayer MJ, Jones S, Prendergast B, et al. Incidence
More informationProphylaxis against Endocarditis: A Brave New World
Prophylaxis against Endocarditis: A Brave New World Ann Bolger MD FACC FAHA University of California, San Francisco Nothing to disclose PREVENTION OF INFECTIVE ENDOCARDITIS: GUIDELINES FROM THE AMERICAN
More informationSurgical Indications of Infective Endocarditis in Children
2016 Annual Spring Scientific Conference of the KSC April 15-16, 2016 Surgical Indications of Infective Endocarditis in Children Cheul Lee, MD Pediatric and Congenital Cardiac Surgery Seoul St. Mary s
More informationModifiers of the clinical course of infective endocarditis
Modifiers of the clinical course of infective endocarditis Ulrika Snygg-Martin M.D., Ph.D. Infectious Diseases Clinic Sahlgrenska University Hospital Gothenburg, Sweden Infective endocarditis : modifiers
More informationInfective Endocarditis عبد المهيمن أحمد
Infective Endocarditis إعداد : عبد المهيمن أحمد أحمد علي Infective endocarditis Inflammation of the heart valve or endocardium of the heart. The agents are usually bacterial, but other organisms can also
More informationInfective Endocarditis Empirical therapy Antibiotic Guidelines. Contents
Infective Endocarditis Empirical therapy Antibiotic Guidelines Classification: Clinical Guideline Lead Author: Antibiotic Steering Group Additional author(s): as above Authors Division: Division of Clinical
More informationAntibiotic Treatment of Adults With Infective Endocarditis Due to Streptococci, Enterococci, Staphylococci, and HACEK Microorganisms
Antibiotic Treatment of Adults With Infective Endocarditis Due to Streptococci, Enterococci, Staphylococci, and HACEK Microorganisms Walter R. Wilson, MD; Adolf W. Karchmer, MD; Adnan S. Dajani, MD; Kathryn
More informationInfections Amenable to OPAT. (Nabin Shrestha + Ajay Mathur)
3 Infections Amenable to OPAT (Nabin Shrestha + Ajay Mathur) Decisions regarding outpatient treatment of infections vary with the institution, the prescribing physician, the individual patient s condition
More informationCommon knowledge regarding prevention of infective endocarditis among general dentists in Japan
Journal of Cardiology (2011) 57, 123 130 available at www.sciencedirect.com journal homepage: www.elsevier.com/locate/jjcc Original article Common knowledge regarding prevention of infective endocarditis
More informationHeart on Fire: Infective Endocarditis. Objectives. Disclosure 8/27/2018. Mary McGreal DNP, RN, ANP-c, CCRN
Heart on Fire: Infective Endocarditis Mary McGreal DNP, RN, ANP-c, CCRN Objectives Discuss the incidence of infective endocarditis? Discuss the pathogenesis of infective endocarditis? Discuss clinical
More informationThe prevention of infective endocarditis
Quality health plans & benefits Healthier living Financial well-being Intelligent solutions The prevention of infective endocarditis An examination of the current use of The Prevention of Infective Endocarditis
More informationCase-based session. Infective Endocarditis. Applying the new guidelines. A case of large vegetation with neurological complication.
Case-based session. Infective Endocarditis. Applying the new guidelines. A case of large vegetation with neurological complication. María Nazarena Pizzi Hospital Universitari Vall d Hebron Barcelona. I
More informationDr Babak Tamizi far MD. Assistant Professor Of Internal Medicine Al-Zahra Hospital Isfahan University Of Medical Sciences
Dr Babak Tamizi far MD. Assistant Professor Of Internal Medicine Al-Zahra Hospital Isfahan University Of Medical Sciences ١ ٢ ٣ A 57-year-old man presents with new-onset fever, shortness of breath, lower
More informationThe following resources related to this article are available online at jada.ada.org ( this information is current as of April 8, 2008 ):
Prevention of infective endocarditis: Guidelines from the American Heart Association: A guideline from the American Heart Association Rheumatic Fever, Endocarditis and Kawasaki Disease Committee, Council
More informationInfective Endocarditis
clinical practice Infective Endocarditis Bruno Hoen, M.D., Ph.D., and Xavier Duval, M.D., Ph.D. This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting
More informationInfective endocarditis (IE) is an
Jason Andrade, MD, Ellamae Stadnick, MD, Aneez Mohamed, MD Infective endocarditis prophylaxis: An update for clinical practice Antibiotic therapy to prevent endocarditis is now considered un - necessary
More informationSupplementary Appendix
Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Kang D-H, Kim Y-J, Kim S-H, et al. Early surgery versus conventional
More informationApport des recommandations européennes
Apport des recommandations européennes Gilbert Habib Cardiology Department- La Timone Marseille - France Bordeaux le 28 Juin 2011 Infective Endocarditis: a changing disease new high-risk subgroups IVDA
More informationInfective endocarditis
Infective endocarditis Today's lecture is about infective endocarditis, the Dr started the lecture by asking what are the most common causative agents of infective endocarditis? 1-Group A streptococci
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE Centre for Clinical Practice
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE Centre for Clinical Practice Review consultation document Review of Clinical Guideline (CG64) - Prophylaxis against infective endocarditis 1. Background
More informationInfective Endocarditis
Frank Lowy Infective Endocarditis 1. Introduction Infective endocarditis (IE) is an infection of the heart valves. A large number of different bacteria are capable of causing this disease. Depending on
More informationSBUH Aminoglycoside Dosing Protocol
Adult Aminoglycoside Dosing for Gram negative infections prior to available serum levels (Excludes patients with cystic fibrosis, OB GYN patients and surgical prophylaxis) Cr Cl 40 ml/min 5 7 mg/kg INT
More informationDOI: /CIRCULATIONAHA
AHA Guideline Prevention of Infective Endocarditis Guidelines From the American Heart Association A Guideline From the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee,
More informationInfective endocarditis
Infective endocarditis Infective endocarditis is universally fatal if unrevealed and untreated. Heart failure due to aquired valvular incompetence or abscesses, frequent embolic phenomena from vegetations
More informationInfective endocarditis (IE) By Assis. Prof. Nader Alaridah MD, PhD
Infective endocarditis (IE) By Assis. Prof. Nader Alaridah MD, PhD Infective endocarditis (IE) is an inflammation of the endocardium.. inner of the heart muscle & the epithelial lining of heart valves.
More informationBacterial Endocarditis
Objectives Bacterial Endocarditis John C. Rotschafer, Pharm. D. Professor College of Pharmacy University of Minnesota Identify which valves are commonly involved with endocarditis Identify common pathogens
More informationReview Article Infective Endocarditis Prophylaxis for Dental Procedures in 2009: What Has Changed?
Hellenic J Cardiol 2009; 50: 493-497 Review Article Infective Endocarditis Prophylaxis for Dental Procedures in 2009: What Has Changed? PEPIE TSOLKA, DEMOSTHENES KATRITSIS Athens Euroclinic, Athens, Greece
More informationGetting the Point of Injection Safety
Getting the Point of Injection Safety Barbara Montana, MD, MPH, FACP Medical Director Communicable Disease Service Outbreak of Enterococcus faecalis endocarditis associated with an oral surgery practice
More informationPrevention of infective endocarditis:
Prevention of infective endocarditis: Guidelines from the American Heart Association A guideline from the American Heart Association Rheumatic Fever, Endocarditis and Kawasaki Disease Committee, Council
More informationBacteriological outcome of combination versus single-agent treatment for staphylococcal endocarditis
Journal of Antimicrobial Chemotherapy (2003) 52, 820 825 DOI: 10.1093/jac/dkg440 Advance Access publication 30 September 2003 Bacteriological outcome of versus single-agent treatment for staphylococcal
More informationCEREBRO VASCULAR ACCIDENTS
CEREBRO VASCULAR S MICHAEL OPONG-KUSI, DO MBA MORTON CLINIC, TULSA, OK, USA 8/9/2012 1 Cerebrovascular Accident Third Leading cause of deaths (USA) 750,000 strokes in USA per year. 150,000 deaths in USA
More informationUpdate on the prevention, diagnosis and management of Infective Endocarditis (IE)
Update on the prevention, diagnosis and management of Infective Endocarditis (IE) Dr.Ahmed Yahya Mohammed Alarhabi MD, MsC,FcUSM,FACC,MAHA Consultant Interventional Cardiologist Head of Cardiac Center
More informationNATIONAL HEART FOUNDATION HOSPITAL & RESEARCH INSTITUTE
Welcome INFECTIVE ENDOCARDITIS: WHERE WE ARE AT 2005? DR MD HABIBUR RAHMAN FCPS(Medicine) NATIONAL HEART FOUNDATION HOSPITAL & RESEARCH INSTITUTE DEFINITION OF INFECTIVE ENDOCARDITIS Infective endocarditis
More informationProphylaxis of Bacterial Edocarditis Revisited
Société Belge d Infectiologie et de Microbiologie clinique 6 november 2008 Prophylaxis of Bacterial Edocarditis Revisited C. Leport, X. Duval, N. Danchin. Paris 7 - Paris 5 Universities, France. Prophylaxis
More informationGuidelines for The Management of Infective Endocarditis
Guidelines for The Management of Infective Endocarditis By Dr. Sinan Butrus F.I.C.M.S Clinical Standards & Guidelines Kurdistan Board For Medical Specialties Infective endocarditis IE is an infection of
More informationDespite advances in medical, surgical, and critical care
Incidence of Infective Endocarditis Caused by Viridans Group Streptococci Before and After Publication of the 2007 American Heart Association s Endocarditis Prevention Guidelines Daniel C. DeSimone, MD;
More informationInfective Endocarditis Caused by Enterococcus faecalis treated with Continuous Infusion of Ampicillin without Adjunctive Aminoglycosides
CASE REPORT Infective Endocarditis Caused by Enterococcus faecalis treated with Continuous Infusion of Ampicillin without Adjunctive Aminoglycosides Taku Ogawa, Masatoshi Sato, Shinsuke Yonekawa, Chiyo
More informationDiagnostic strategy. Dr Pilar Tornos Hospital Vall d Hebron Barcelona
Diagnostic strategy Dr Pilar Tornos Hospital Vall d Hebron Barcelona Faculty disclosure Pilar Tornos I disclose the following financial relationships: Paid speaker for Recordati, Edwards. Diagnosis of
More informationTrend and Contributing Factors of In-Hospital Deaths in Patients With Infective Endocarditis Over the Last Twenty Years
J Cardiol 26 Feb; 472: 73 81 2 Trend and Contributing Factors of In-Hospital Deaths in Patients With Infective Endocarditis Over the Last Twenty Years Koichiro Toshiaki Kyomi Naoko Hiroshi EJIMA, MD OKA,
More informationDisclosures. Native Valve Endocarditis and its Complications. Outline. Outline. Basics. Basics 3/23/2017
Native Valve Endocarditis and its Complications SCVP and Binford Dammin Society of Infectious Disease Pathologists Shared Companion Meeting USCAP 2017 Annual Meeting Disclosures Relevant financial relationships
More informationA Predictable Outcome of a Preventable Disease. Sanjay Kamboj, MD; Shaminder Gupta, MD; Glenn P. Kelley, MD; Fred Helmcke, MD; and Fred A.
Clinical Case of the Month A Predictable Outcome of a Preventable Disease Sanjay Kamboj, MD; Shaminder Gupta, MD; Glenn P. Kelley, MD; Fred Helmcke, MD; and Fred A. Lopez, MD Infective endocarditis is
More informationEnterococcal endocarditis: 107 cases from the international collaboration on endocarditis merged database
The American Journal of Medicine (2005) 118, 759-766 CLINICAL RESEARCH STUDY AJM Theme Issue: CARDIOLOGY Enterococcal endocarditis: 107 cases from the international collaboration on endocarditis merged
More informationInfective Endocarditis
Infective Endocarditis Infective Endocarditis Historical Perspective.. A concretion larger than a pigeon s egg; contained in the left auricle. Burns, 1809 Osler s Gulstonian lectures provided the 1 st
More informationINFECTIVE ENDOCARDITIS: WHAT IS CHANGED IN EPIDEMIOLOGY AND PROPHYLAXIS
Acta Medica Mediterranea, 2012, 28: 311 INFECTIVE ENDOCARDITIS: WHAT IS CHANGED IN EPIDEMIOLOGY AND PROPHYLAXIS DONATO D AGOSTINO*, LUCREZIA BOTTALICO**, LUIGI SANTACROCE*** *Aggregate Professor, Section
More informationShabib A. Alhadheri, M.D.
Pediatrics in the Red Rocks Sedona, Arizona June 20-22, 2008 Shabib A. Alhadheri, M.D. Pediatric Cardiologist Disclosure I I have no relevant financial relationships with the manufacturer(s) of any commercial
More informationIE with cerebral hemorrhage
IE with cerebral hemorrhage Gilbert Habib / Patrizio Lancellotti La Timone Hospital Marseille - France Palermo, 26 April 2018 Case report: aortic bioprosthetic IE History of the disease 75 year-old man
More informationPre- and Post-operative Dental Focus of Patients with Prosthetic Heart Valves
ISPUB.COM The Internet Journal of Cardiovascular Research Volume 6 Number 1 Pre- and Post-operative Dental Focus of Patients with Prosthetic Heart Valves R Schmelzeisen, F Yabroudi, A Dannan Citation R
More informationEarly Surgery versus Conventional Treatment for Infective Endocarditis
T h e n e w e ngl a nd j o u r na l o f m e dic i n e original article Early Surgery versus Treatment for Infective Endocarditis Duk-Hyun Kang, M.D., Ph.D., Yong-Jin Kim, M.D., Ph.D., Sung-Han Kim, M.D.,
More informationEarly oral switch for antibiotic treatment of infective endocarditis
AEPEI: Association pour l Etude et la Prévention des Endocardites Infectieuses Early oral switch for antibiotic treatment of infective endocarditis Prof. Pierre Tattevin Infectious Diseases & ICU, INSERM
More informationInfective Endocarditis: Rationale for Revised Guidelines for Antibiotic Prophylaxis
CM&R Rapid Release. Published online ahead of print July 16, 2009 as Clinical Perspective Infective Endocarditis: Rationale for Revised Guidelines for Antibiotic Prophylaxis Prabhakaran P. Gopalakrishnan,
More informationRochester Patient Safety C. difficile Prevention Collaborative: Long Term Care Antimicrobial Stewardship (funded by NYSDOH)
Rochester Patient Safety C. difficile Prevention Collaborative: Long Term Care Antimicrobial Stewardship (funded by NYSDOH) Clinical Practice Guideline* for the Diagnosis and Management of Acute Bacterial
More informationMichael Stander, Pharm.D.
Michael Stander, Pharm.D. Endocarditis: Goals Epidemiology Presentation of acute and subacute. Diagnosis: What is Dukes Criteria and how do we approach the diagnosis of endocarditis? Treatment: Understand
More informationQuelles stratégies pour le diagnostic, la prévention et le traitement des accidents emboliques cérébraux dans l'endocardite infectieuse?
Quelles stratégies pour le diagnostic, la prévention et le traitement des accidents emboliques cérébraux dans l'endocardite infectieuse? Bruno Hoen ICE 16 es JNI, Nancy, du 10 au 12 juin 2015 AEPEI Déclaration
More informationMedically Compromised Patients
Medically Compromised Patients (Part I) Ra ed Salma BDS, MSc, JBOMFS, MFDRCSI All information in this file is updated till April, 2014 Cardiovascular Diseases I. Ischemic Heart Disease (IHD) 1. Angina
More informationVancomycin: Class: Antibiotic.
Vancomycin: Class: Antibiotic. Indications: Treatment of patients with infections caused by staphylococcal species and streptococcal Species. Available dosage form in the hospital: 1G VIAL, 500MG VIAL.
More informationManagement of infective endocarditis in children
Management of infective endocarditis in children Ashutosh Marwah, MD* Savitri Shrivastava, MD DM FAMS FACC* INTRODUCTION Infective endocarditis (IE) continues to remain a serious disease despite advances
More informationPeninsula Dental Social Enterprise (PDSE) Antibiotic Prophylaxis for. Infective Endocarditis. Version 1.0
Peninsula Dental Social Enterprise (PDSE) Antibiotic Prophylaxis for Infective Endocarditis Version 1.0 Date approved: September 2018 Approved by: The Board Review due: August 2019 Policy will be updated
More informationACCME/Disclosures 4/13/2016 IDPB
ACCME/Disclosures The USCAP requires that anyone in a position to influence or control the content of CME disclose any relevant financial relationship WITH COMMERCIAL INTERESTS which they or their spouse/partner
More informationIndications chirurgicales dans l endocardite infectieuse
Indications chirurgicales dans l endocardite infectieuse Bruno Hoen ICE AEPEI Agenda Indications of surgery in IE: current guidelines Impact of early valve surgery (EVS) on the prognosis of IE: is the
More informationVALVULAR HEART DISEASE
VALVULAR HEART DISEASE Stenosis: failure of a valve to open completely, obstructing forward flow. - almost always due to a chronic process (e.g., calcification or valve scarring). Insufficiency : failure
More information, David Stultz, MD.
http://www.dilbert.com Infective Endocarditis David Stultz, MD Cardiology Fellow, PGY 4 December 8, 2004 Handouts available in PDF format at www.drstultz.com Topics to be covered Epidemiology Microbiology
More informationAntithrombotic therapy in patients with transient ischemic attack / stroke (acute phase <48h)
Antithrombotic therapy in patients with transient ischemic attack / stroke (acute phase
More informationApril 16, 09:00-09:15 중앙대학교 윤신원
April 16, 09:00-09:15 중앙대학교 윤신원 When to perform Echocardiography in IE? Vegetations?(pathologic Whatever the level hallmark) of suspicion Intracardiac abscess? Confirm or R/O at the Earliest opportunity.
More informationINFECTIVE ENDOCARDITIS IN CHILDREN
INFECTIVE ENDOCARDITIS IN CHILDREN Rohayati Taib RIPAS Hospital, Bundar Seri Begawan, Brunei Darussalam Infective Endocarditis (IE) is a microbial infection of the endocardium. It encompasses both bacterial
More informationExperience in heart transplant as salvage treatment for infective endocarditis
Experience in heart transplant as salvage treatment for infective endocarditis Prof. Pierre Tattevin Infectious Diseases & ICU, Rennes Univ. Hosp INSERM U 835, Hôpital Pontchaillou, Rennes, France AEPEI:
More informationAPPENDIX A NORTH AMERICAN SYMPTOMATIC CAROTID ENDARTERECTOMY TRIAL
APPENDIX A Primary Findings From Selected Recent National Institute of Neurological Disorders and Stroke-Sponsored Clinical Trials That Have shaped Modern Stroke Prevention Philip B. Gorelick 178 NORTH
More informationImpact of Early Surgical Treatment on Postoperative Neurologic Outcome for Active Infective Endocarditis Complicated by Cerebral Infarction
Impact of Early Surgical Treatment on Postoperative Neurologic Outcome for Active Infective Endocarditis Complicated by Cerebral Infarction Daisuke Yoshioka, MD, Taichi Sakaguchi, MD, PhD, Takashi Yamauchi,
More informationSurvivor Treatment Selection Bias and Outcomes Research A Case Study of Surgery in Infective Endocarditis
Survivor Treatment Selection Bias and Outcomes Research A Case Study of Surgery in Infective Endocarditis Raymond W. Sy, MBBS; Paul G. Bannon, MBBS, PhD; Matthew S. Bayfield, MBBS; Chris Brown, BSci; Leonard
More informationNatural History of Aortic Valve Endocarditis in Rats
INFECTION AND IMMUNITY, JUlY 192, p. 127-131 19-9567/2/7127-5$2./ Vol. 37, No. 1 Natural History of Aortic Valve Endocarditis in Rats ERIC HtRAIEF, MICHEL P. GLAUSER,* AND LAWRENCE R. FREEDMANt Division
More informationEndodontic Microbiology
Endodontic Microbiology The indigenous oral microflora may gain access to the pulp and impair its function along a number of different routes: Direct exposure of the pulp tissue i.e., following caries,
More informationChallenging clinical situation
Challenging clinical situation A young patient with prosthetic aortic valve endocarditis Gilbert Habib La Timone Hospital Marseille - France October 25 th 2014 Case report History of the disease Clinical
More informationVancomycin Orion , Version 2 Public Summary of the Risk Management Plan
Vancomycin Orion 18.1.2016, Version 2 Public Summary of the Risk Management Plan VI.2 Elements for a Public Summary Vancomycin Orion is intravenously administered glycopeptide antibiotic. It is indicated
More informationEchocardiographic Diagnosis of Rheumatic Heart Disease
Echocardiographic Diagnosis of Rheumatic Heart Disease Nigel Wilson Paediatric Cardiologist Paediatric and Congenital Cardiac Services Auckland City and Starship Hospitals Auckland, New Zealand Auckland
More information, David Stultz, MD.
http://www.dilbert.com Infective Endocarditis David Stultz, MD Cardiology Fellow, PGY 6 August 31, 2005 Topics to be covered Epidemiology Microbiology Clinical presentation Physical Exam Findings Diagnostic
More informationAutologous Heparinized Oxygenated Blood Reperfusion in Acute Ischemic Stroke Caused by Infective Endocarditis:A Case Report
267 Autologous Heparinized Oxygenated Blood Reperfusion in Acute Ischemic Stroke Caused by Infective Endocarditis:A Case Report Lung Chan 1, Yen-Jun Lai 2, Hon-Man Liu 3, Ai-Hsien Li 4 Abstract- Purpose:
More informationCase Report Possible Usefulness of Gadolinium-Enhanced Brain MRI for Evaluating Risk of Perioperative Hemorrhage: A Case of Infective Endocarditis
Case Reports in Cardiology, Article ID 158041, 4 pages http://dx.doi.org/10.1155/2014/158041 Case Report Possible Usefulness of Gadolinium-Enhanced Brain MRI for Evaluating Risk of Perioperative Hemorrhage:
More informationHospital-wide Impact of Mandatory Infectious Disease Consultation on Staphylococcus aureus Septicemia
Hospital-wide Impact of Mandatory Infectious Disease Consultation on Staphylococcus aureus Septicemia Amanda Guth 1 Amy Slenker MD 1,2 1 Department of Infectious Diseases, Lehigh Valley Health Network
More informationCDA Position on Antibiotic Prophylaxis for Dental Patients at Risk
Antibiotic Prophylaxis for Dental Patients at Risk Certain categories of invasive dental treatment are known to produce significant bacteremias. Such bacteremias, although transient, may be detrimental
More informationÉpidémiologie des endocardites infectieuses à Staphylococcus aureus (Epidemiology of S. aureus endocarditis)
Épidémiologie des endocardites infectieuses à Staphylococcus aureus (Epidemiology of S. aureus endocarditis) Lyon, 30 Novembre 2018 Univ.-Prof. Dr. med. Achim J. Kaasch Institut für Medizinische Mikrobiologie
More informationInfective Endocarditis for Primary Care Physicians
Infective Endocarditis for Primary Care Physicians David N Gilbert, MD Disclosures Consultant to: Merck Pfizer Medicine Company Cempra 1 Introduction There are roughly 30,000 new cases of IE in the US
More informationCase Report Daptomycin Failure for Treatment of Pulmonary Septic Emboli in Native Tricuspid and Mitral Valve
Case Reports in Infectious Diseases Volume 2013, Article ID 653582, 4 pages http://dx.doi.org/10.1155/2013/653582 Case Report Daptomycin Failure for Treatment of Pulmonary Septic Emboli in Native Tricuspid
More informationSepsis and Infective Endocarditis
Sepsis and Infective Endocarditis Michal Holub Department of Infectious Diseases First Faculty of Medicine Charles University in Prague and University Military Hospital Bacteremia and Sepsis bacteremia
More informationMethicillin-Resistant Staphylococcus aureus (MRSA) S urveillance Report 2008 Background Methods
Methicillin-Resistant Staphylococcus aureus (MRSA) Surveillance Report 2008 Oregon Active Bacterial Core Surveillance (ABCs) Office of Disease Prevention & Epidemiology Oregon Department of Human Services
More informationClinical guideline Published: 17 March 2008 nice.org.uk/guidance/cg64
Prophylaxis against infective endocarditis: antimicrobial prophylaxis against infective e endocarditis in adults and children undergoing interventionalentional procedures Clinical guideline Published:
More informationStarting or Resuming Anticoagulation or Antiplatelet Therapy after ICH: A Neurology Perspective
Starting or Resuming Anticoagulation or Antiplatelet Therapy after ICH: A Neurology Perspective Cathy Sila MD George M Humphrey II Professor and Vice Chair of Neurology Director, Comprehensive Stroke Center
More informationEndocarditis in the elderly
Endocarditis in the elderly Gilbert Habib Département de Cardiologie - Timone Marseille Eurovalves Barcelona 2017 Endocarditis in the octogenarian Gilbert Habib Département de Cardiologie - Timone Marseille
More informationPrimary Care practice clinics within the Edmonton Southside Primary Care Network.
INR Monitoring and Warfarin Dose Adjustment Last Review: November 2016 Intervention(s) and/or Procedure: Registered Nurses (RNs) adjust warfarin dosage according to individual patient International Normalized
More informationFamily Medicine Clinical Pharmacy Forum Vol. 3, Issue 3 (May/June 2007)
1 Family Medicine Clinical Pharmacy Forum Vol. 3, Issue 3 (May/June 2007) Family Medicine Clinical Pharmacy Forum is a brief bi-monthly publication from the Family Medicine clinical pharmacists distributed
More informationChiayi, Taiwan. Abstract
DOI 10.6314/JIMT.201810_29(5).05 2018 29 309-316 Clinical Features and Risks Associated with In-hospital Mortality in Patients with Infective Endocarditis at A Medical Center in Central Taiwan from 2012
More informationInfective Endocarditis:
CME Workshop Infective Endocarditis: Prophylaxis, Diagnosis and Management Presented at a CME program, University of Manitoba, Winnipeg, Manitoba, December 2001. By Davinder S. Jassal, MD; and John M.
More informationGeneral management of infective endocarditis
General management of infective endocarditis Team approach in infective endocarditis Gilbert Habib La Timone Hospital Marseille - France Eurovalves Barcelona 2017 The echolab «Heart Team" Infective Endocarditis
More informationInfective Endocarditis in Elderly Patients
AGING AND INFECTIOUS DISEASES Thomas T. Yoshikawa, Section Editor INVITED ARTICLE Infective Endocarditis in Elderly Patients Vinod K. Dhawan Charles R. Drew University of Medicine and Science, Martin Luther
More informationSTUDY OF IMPETIGO AND THE RESISTANCE PATTERN OF THE ISOLATES TO VARIOUS ANTIBIOTICS
STUDY OF IMPETIGO AND THE RESISTANCE PATTERN OF THE ISOLATES TO VARIOUS ANTIBIOTICS Abstract Pages with reference to book, From 129 To 132 Aqeel Ahmad, Khursheed Ali Khan ( Department of Microbiology,
More information